Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ackman: J.C. Penney Company, Inc. (JCP), Herbalife Ltd. (HLF), Canadian Pacific Railway Limited (USA) (CP)

Page 1 of 2

Bill Ackman’s fund, Pershing Square, is one of the highest profile hedge funds in the world. As the company takes large, concentrated bets on major American companies, and often works to change their business structure, the actions of the fund can have a real impact on investors’ portfolios. Anyone holding shares of J.C. Penney Company, Inc. (NYSE:JCP) or Canadian Pacific Railway Limited (USA) (NYSE:CP) is no doubt aware of Pershing Square’s ability to move stocks. If the fund gets involved with a company, there’s going to be some volatility, one way or the other.

While Pershing Square’s second quarter letter to investors touches on all of the fund’s positions, I’ve highlighted what I consider to be the three biggest investment takeaways.

J.C. Penney: Admitting defeat

After two arduous years, Ackman has finally admitted his investment in J.C. Penney Company, Inc. (NYSE:JCP) was a mistake.


Perhaps to soothe his investors, Ackman deflects blame for the failure of former CEO Ron Johnson, noting that all members of the retailer’s board (not just him) wanted to hire Johnson back in 2011. At the same time, Ackman says he has been upfront about the high risk/high reward nature of his J.C. Penney investment. Interestingly, he notes that his fund’s two biggest failures (J.C. Penney Company, Inc. (NYSE:JCP) and Target) have been retail stocks. Perhaps the activist will avoid retailers for the foreseeable future.

After reaching an agreement with J.C. Penney Company, Inc. (NYSE:JCP)’s board, Ackman unloaded his shares earlier this week. He had said he was prepared to hold J.C. Penney shares until more interesting investment opportunities come along — something else must have caught his eye. Since Ackman’s sale, J.C. Penney shares have moved lower, but some analysts see it as a positive. Oppenheimer’s Brian Nagel wrote that it would be positive for the company in the long-run.

With Ackman out, J.C. Penney Company, Inc. (NYSE:JCP) is an interesting situation. Management appears to be committed to bringing back the old J.C. Penney with coupons and private label clothing like St. John’s Bay. That could help stabilize the situation, and should the customers driven away by Johnson return, J.C. Penney Company, Inc. (NYSE:JCP) could see same-store sales growth. On the company’s recent earnings call, it said each month of the recent quarter was better than the last, and it expects this trend to continue through the end of the year.

Not backing down from Herbalife

Currently, Pershing Square’s bet against multi-level marketing firm Herbalife Ltd. (NYSE:HLF) is underwater. Ackman has lost about $300 million on the position, according to Reuters.

Yet, he’s not backing down. Instead, he reaffirmed his position on the company — that it’s a pyramid scheme destined to collapse — and rebuked many of the bullish arguments for the stock.

Ackman notes that last quarter, the company saw its earnings growth decline. Herbalife Ltd. (NYSE:HLF) is still profitable, but earnings are growing at a lesser pace. Herbalife Ltd. (NYSE:HLF) bulls have argued that the company should be able to authorize a large share repurchase program in the near-future, but Ackman isn’t buying it. Given that much of its cash is overseas, Ackman believes that the company would have to borrow money to repurchase shares. If, as he alleges, the company is a pyramid scheme, any institution that loaned Herbalife Ltd. (NYSE:HLF) money would be out of luck if the FTC shuts the company down.

And that’s still what Ackman expects, with more certainty than ever. Although he didn’t explain exactly why, Ackman writes that he’s now more confident in regulators taking action against the company.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!